Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancerQingjian Li, Hai Hu, Wenkui Fu et al.|Nature Communications|2020Cited by 187
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant miceLaura N. Burga, Gerburg M. Wulf|Breast Cancer Research|2011Cited by 84
Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast CancerHui Liu, Lewis C. Cantley, Charles J. Murphy et al.|Cancer Discovery|2017Cited by 76
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approachVarduhi Petrosyan, Michael T. Lewis, Lacey E. Dobrolecki et al.|iScience|2022Cited by 35
Chromosome 12p Amplification in Triple-Negative/ <i>BRCA1-</i> Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin SensitivityJorge Gómez‐Miragaya, Eva González‐Suárez, Ander Díaz‐Navarro et al.|Cancer Research|2019Cited by 19